What is LB Pharmaceuticals Inc Common Stock's Market Cap?

LB Pharmaceuticals Inc Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is LB Pharmaceuticals Inc Common Stock's Enterprise Value?

LB Pharmaceuticals Inc Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is LB Pharmaceuticals Inc Common Stock's Net Income (TTM)?

LB Pharmaceuticals Inc Common Stock's Net Income (TTM) is -$85.7M, based on as-reported figures from SEC (XBRL) filings.

What is LB Pharmaceuticals Inc Common Stock's Diluted EPS (TTM)?

LB Pharmaceuticals Inc Common Stock's Diluted EPS (TTM) is -2.66, based on as-reported figures from SEC (XBRL) filings.

What is LB Pharmaceuticals Inc Common Stock's Net Debt?

LB Pharmaceuticals Inc Common Stock's Net Debt is -$327.8M, based on as-reported figures from SEC (XBRL) filings.

LB Pharmaceuticals Inc Common Stock (LBRX) Financial Statements

LB Pharmaceuticals Inc Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00XNP5MR3

XNAS · usd

49.39▲ 0.05 (0.10%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close49.34

Day's Range47.15 – 49.62

52-Week Range13.36 – 50.16

Volume300.8K

Avg Volume351.9K

Share Statistics

Shares Outstanding

Employees27

ExchangeXNAS

Listed2025-09-11

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about LB Pharmaceuticals Inc Common Stock (LBRX)

What is LB Pharmaceuticals Inc Common Stock's Market Cap?: LB Pharmaceuticals Inc Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is LB Pharmaceuticals Inc Common Stock's Enterprise Value?: LB Pharmaceuticals Inc Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is LB Pharmaceuticals Inc Common Stock's Net Income (TTM)?: LB Pharmaceuticals Inc Common Stock's Net Income (TTM) is -$85.7M, based on as-reported figures from SEC (XBRL) filings.
What is LB Pharmaceuticals Inc Common Stock's Diluted EPS (TTM)?: LB Pharmaceuticals Inc Common Stock's Diluted EPS (TTM) is -2.66, based on as-reported figures from SEC (XBRL) filings.
What is LB Pharmaceuticals Inc Common Stock's Net Debt?: LB Pharmaceuticals Inc Common Stock's Net Debt is -$327.8M, based on as-reported figures from SEC (XBRL) filings.